NorthWest Biotherapeutics Inc (NWBO)

[Flexroy]

To add colour to this even though the numbers aren't huge yet there are some (11) tutes involved.

These are a truely unique confluence of positive factors creating significant tailwinds for our company. I have said many times that we are largely derisked though now of course with the caveat of minor dilution. Yet we still have an immensely valuable oncology platform and a pending combination patent. Even better times are soon ahead in my opinion which should be worth celebrating.